In the FOXM1 paradigm where hypophosphorylated IDRs stabilize oncogenic condensates, the disruptive peptide FIP4 successfully inhibits tumor progression by dissolving phase-separated FOXM1 condensates [87]. This evidence concerns the gene FOXM1 and neoplasm.